Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hannah Benoliel"'
Autor:
Adam S. Kibel, Russell Z. Szmulewitz, Glenn J. Bubley, Hannah Benoliel, Andrew A. Wagner, Alicia K. Morgans, Sean McBride, James A. Eastham, Anuradha Gopalan, Min Yuen Teo, Eric A. Klein, A. Goh, Howard I. Scher, Scott E. Eggener, Shilpa Gupta, Paul Nguyen, Stanley L. Liauw, Mary-Ellen Taplin, Irving D. Kaplan
Publikováno v:
Annals of Oncology. 32:S667-S668
Autor:
Anuradha Gopalan, Audrey Gill, Alisa Tubbs, Rick Wenstrup, Amanda Anderson, Adam Jendrisak, Joseph D. Schonhoft, Carbone Emily, James Lu, Cole Gilbertson, Samir Zaidi, Howard I. Scher, Hannah Benoliel, Eva Wang, Ethan Barnett, Joshua Jones, Niamh M. Keegan
Publikováno v:
Cancer Research. 81:463-463
Background: The increasing availability and earlier use of life prolonging drugs targeting the androgen receptor signaling axis (ARSI) has resulted in an increase in the frequency of late state tumors with “small cell/neuroendocrine like (SC/NE-L)
Autor:
Joseph D. Schonhoft, Howard I. Scher, Rick Wenstrup, Emily Carbone, Audrey Gill, Samir Zaidi, Adam Jendrisak, Ethan Barnett, Anuradha Gopalan, Hannah Benoliel, Jiyun Byun
Publikováno v:
Journal of Clinical Oncology. 38:5572-5572
5572 Background: The increasing availability and earlier use of life prolonging drugs targeting the androgen receptor signaling axis (ARSI) has resulted in an increase in the frequency of late state tumors with “small cell/neuroendocrine (NESC) phe
Autor:
Adam S. Kibel, Anuradha Gopalan, Hannah Benoliel, Howard I. Scher, Min Yuen Teo, Sean McBride, Mary-Ellen Taplin, James A. Eastham, Paul L. Nguyen, Rosina T. Lis
Publikováno v:
Journal of Clinical Oncology. 37:TPS349-TPS349
TPS349 Background: Therapeutic advances in the management of metastatic castration-resistant prostate cancer (mCRPC) have not been matched in non-castrate states. A key obstacle is the traditional paradigm in which therapies with significant benefit